Literature DB >> 19809888

Coronary heart disease risk screening: the community pharmacy Healthy Heart Assessment Service.

Parastou Donyai1, Melandi Van den Berg.   

Abstract

OBJECTIVES: We examined the characteristics and CHD risks of people who accessed the free Healthy Heart Assessment (HHA) service operated by a large UK pharmacy chain from August 2004 to April 2006.
METHODS: Associations between participants' gender, age, and socioeconomics were explored in relation to calculated 10-year CHD risks by cross-tabulation of the data. Specific associations were tested by forming contingency tables and using Pearson chi-square (chi(2)).
RESULTS: Data from 8,287 records were analysable; 5,377 were at low and 2,910 at moderate-to-high CHD risk. The likelihood of moderate-to-high risk for a male versus female participant was significantly higher with a relative risk ratio (RRR) 1.72 (P < 0.001). A higher percentage of those in socioeconomic categories 'constrained by circumstances' (RRR 1.15; P < 0.05) and 'blue collar communities' (RRR 1.13; P < 0.05) were assessed with moderate-to-high risk compared to those in 'prospering suburbs'.
CONCLUSIONS: People from 'hard-to-reach' sectors of the population, men and people from less advantaged communities, accessed the HHA service and were more likely to return moderate-to-high CHD risk. Pharmacists prioritized provision of lifestyle information above the sale of a product. Our study supports the notion that pharmacies can serve as suitable environments for the delivery of similar screening services.

Entities:  

Mesh:

Year:  2009        PMID: 19809888     DOI: 10.1007/s11096-009-9338-4

Source DB:  PubMed          Journal:  Pharm World Sci        ISSN: 0928-1231


  3 in total

Review 1.  Systematic review of the effectiveness of community pharmacy-based interventions to reduce risk behaviours and risk factors for coronary heart disease.

Authors:  Alison Blenkinsopp; Claire Anderson; Miriam Armstrong
Journal:  J Public Health Med       Date:  2003-06

2.  Prediction of coronary heart disease using risk factor categories.

Authors:  P W Wilson; R B D'Agostino; D Levy; A M Belanger; H Silbershatz; W B Kannel
Journal:  Circulation       Date:  1998-05-12       Impact factor: 29.690

3.  Explaining the decline in coronary heart disease mortality in England and Wales between 1981 and 2000.

Authors:  Belgin Unal; Julia Alison Critchley; Simon Capewell
Journal:  Circulation       Date:  2004-03-01       Impact factor: 29.690

  3 in total
  4 in total

Review 1.  Community pharmacy COPD services: what do researchers and policy makers need to know?

Authors:  Michael J Twigg; David J Wright
Journal:  Integr Pharm Res Pract       Date:  2017-02-07

2.  A community pharmacy-based cardiovascular risk screening service implemented in Iran.

Authors:  Zahra Jahangard-Rafsanjani; Negar Hakimzadeh; Amir Sarayani; Sheyda Najafi; Kazem Heidari; Mohammad R Javadi; Molouk Hadjibabaie; Kheirollah Gholami
Journal:  Pharm Pract (Granada)       Date:  2017-06-30

3.  The effectiveness of screening for diabetes and cardiovascular disease risk factors in a community pharmacy setting.

Authors:  Andrew Willis; Peter Rivers; Laura J Gray; Melanie Davies; Kamlesh Khunti
Journal:  PLoS One       Date:  2014-04-01       Impact factor: 3.240

4.  Will the Public Engage with New Pharmacy Roles? Assessing Future Uptake of a Community Pharmacy Health Check Using a Discrete Choice Experiment.

Authors:  Gin Nie Chua; Christine Bond; Terry Porteous; Mandy Ryan
Journal:  Patient       Date:  2022-01-24       Impact factor: 3.481

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.